Erlotinib, erlotinib-sulindac vs. placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer

Saved in:
Bibliographic Details
Published in:Clinical cancer research 2014-04, Vol.20 (12), p.3289-3298
Main Authors: Gross, Neil D., Bauman, Julie E., Gooding, William E., Denq, William, Thomas, Sufi M., Wang, Lin, Chiosea, Simion, Hood, Brian L., Flint, Melanie S., Sun, Mai, Conrads, Thomas P., Ferris, Robert L., Johnson, Jonas T., Kim, Seungwon, Argiris, Athanassios, Wirth, Lori, Nikiforova, Marina N., Siegfried, Jill M., Grandis, Jennifer R.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1078-0432
DOI:10.1158/1078-0432.CCR-13-3360